Stocks and Investing Stocks and Investing
Tue, December 13, 2016

Madhu Kumar Downgraded (ABUS) to Hold and Decreased Target to $3 on, Dec 13th, 2016


Published on 2024-10-25 19:37:48 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of Chardan Capital, Downgraded "Arbutus Biopharma Corporation" (ABUS) to Hold and Decreased Target from $4 to $3 on, Dec 13th, 2016.

Madhu, nor any peers, have made any analyst calls on ABUS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources